Systematix is bullish on Dishman Pharma has recommended buy rating on the stock with a target price of Rs 285 in its research report dated February 14, 2017.

Buy Dishman Pharma; target of Rs 198: Karvy

Karvy is bullish on Dishman Pharma has recommended buy rating on the stock with a target price of Rs 198 in its research report dated August 05, 2016.

Buy Dishman Pharma; target of Rs 200: Dynamic Levels

Dynamic Levels is bullish on Dishman Pharma has recommended buy rating on the stock with a target price of Rs 200 in its research report dated June 30, 2016.

Buy Dishman Pharma; target of Rs 189: Angel Broking

Angel Broking is bullish on Dishman Pharmaceuticals & Chemicals and has recommended buy rating on the stock with a target of Rs 189 in its research report dated June 10, 2015.

Buy Dishman Pharma; target of Rs 217: Angel Broking

Angel Broking is bullish on Dishman Pharmaceuticals and has recommended buy rating on the stock with a target of Rs 217 in its November 17, 2014 research report.

Buy Dishman Pharma; target of Rs 177: Angel Broking

Angel Broking is bullish on Dishman Pharma and has recommended buy rating on the stock with a target of Rs 177 in its August 18, 2014 research report.

Buy Dishman Pharma; target of Rs 123: Angel Broking

Brokerage house Angel Broking is bullish on Dishman Pharmaceuticals & Chemicals and has recommended 'Buy' rating on the stock with a target price of Rs 123 in its research report dated June 03, 2014.

Buy Dishman Pharma, HT Media: Angel Broking

Brokerage house Angel Broking is bullish Dishman Pharmaceuticals & Chemicals, HT Media and has recommended to buy both the stocks for target price of Rs 117 and Rs 84 respectively in its February 2014 research reports.

Buy Dishman Pharma, TVS Motor advises Systematix Shares

Systematix Shares is bullish on Dishman Pharmaceuticals & Chemicals, TVS Motor Company and has recommended to buy both the stocks for target price of Rs 93 and Rs 59.50 respectively, in its research report dated December 18, 2013.

Buy CEAT, Dishman Pharmaceuticals: Angel Broking

Brokerage house Angel Broking is bullish on CEAT, Dishman Pharmaceuticals and has recommended buy rating on both the stocks with a target price of Rs 170 and Rs 132 respectively in its research reports dated August 2, 2013.

Buy Dishman Pharma; target of Rs 155: Angel Broking

Angel Broking is bullish on Dishman Pharma and has recommended buy rating on the stock with a target of Rs 155 in its February 11, 2013 research report.

Motilal Oswal neutral on Dishman Pharma

Motilal Oswal has maintained neutral rating on Dishman Pharma with a target of Rs 103, in its August 2, 2012 research report.

Buy Dishman Pharma; target of Rs 92: Angel Broking

Angel Broking is bullish on Dishman Pharma and has recommended buy rating on the stock with a target of Rs 92 in its May 15, 2012 research report.

Reduce Dishman Pharma; target of Rs 61: KRChoksey

KRChoksey is bearish on Dishman Pharma and has recommended reduce rating on the stock with a target of Rs 61 in its February 13, 2012 research report.

Accumulate Dishman Pharma; target of Rs 64: Dolat Capital

Dolat Capital is bullish on Dishman Pharma and has recommended accumulate rating on the stock with a target of Rs 64 in its February 10, 2012 research report.

Buy Dishman Pharmaceuticals; target Rs 68: Angel Broking

Angel Broking is bullish on Dishman Pharmaceuticals and has recommended buy rating on the stock with a target price of Rs 68 in its November 16, 2011 research report.

Hold Dishman Pharma; target Rs 100: KRChoksey

KRChoksey has maintained hold rating on Dishman Pharmaceuticals (DPL) with a target price of Rs 100 in its July 29, 2011 research report.

Buy Dishman Pharma; target of Rs 133: Angel Broking

Angel Broking is bullish on Dishman Pharma and has recommended buy rating on the stock with a target of Rs 133 in its August 1, 2011 research report.

Buy Dishman Pharma; target of Rs 133: Angel Broking

Angel Broking is bullish on Dishman Pharma and has recommended buy rating on the stock with a target of Rs 133 in its May 27, 2011 research report.

Hold Dishman Pharma; target of Rs 103: KRChoksey

KRChoksey has recommended hold rating on Dishman Pharma with a target of Rs 103, in its May 27, 2011 research report.

Accumulate Dishman Pharma; target of Rs 125: Emkay

Emkay Global Financial Services is bullish on Dishman Pharmaceuticals & Chemicals and has recommended accumulate rating on the stock with a target of Rs 125 in its April 11, 2011 research report.

Which 7 stocks is Emkay bearish on?

Emkay Global Financial Services has come out with a report on top recommendation.

Buy Dishman Pharma; target of Rs 123: Angel Broking

Angel Broking is bullish on Dishman Pharmaceuticals and has recommended buy rating on the stock with a target of Rs 123 in its February 15, 2011 research report.